The aim of this study was to investigate whether and how IL-18 concentration in serum is prospectively associated with cardiovascular deaths in the 2-year follow-up in patients with various stages of CKD and the history of AMI in the previous year, but without diabetes mellitus. This evidence concerns the gene IL18 and diabetes mellitus.